SemiNex Wins NIH Grant for Laser Vaccine Research
SemiNex Corp. has received a $146,905 Small Business Technology Transfer grant from the National Institutes of Health to develop small laser devices to enhance immune responses to vaccines.
Existing lasers used to enhance immune responses to vaccines are large and expensive, and scientists who work with vaccines do not have ready access to technical assistance, the company said. The grant will enable the development of smaller lasers and allow testing device kits to be sent to laboratories working on new vaccines.
SemiNex is collaborating with Dr. Satoshi Kashiwagi of the Vaccine and Immunotherapy Center at Massachusetts General Hospital; he discovered that treatment of the skin with certain IR lasers promotes better immune responses to vaccines.
For more information, visit
www.seminex.com.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024